ZofranLegal.com reports on the latest news surrounding Zofran birth defect lawsuits consolidated in multidistrict litigation 2657 in Boston, Massachusetts. The lawsuits, which now number over 200 individual cases, are being overseen by the Honorable Judge F. Dennis Saylor IV.
In order to assist in streamlining this high number of complaints, and ease the process of transferring previously-filed lawsuits, Zofran manufacturer and defendant GlaxoSmithKline has reportedly agreed to “waive formal service of process” for the lawsuits and summons. Judge Saylor announced this decision during his 7th official order, which was released to the public on December 17th of 2015.
In non-legal terms, “service of process” refers to the method in which a defendant will be notified of a primary legal action. Across the United States, service of process is valued so heavily that a lawsuit will be unable to start before it is properly completed. Typically, in order for service of process to be considered completed, a set of documents must be delivered to whomever needs to be served. These legal documents, are known to those involved as “process,” and each jurisdiction has their own requirements regarding what documents should be included in the process.
Plaintiffs are unable to serve process, but anyone older than 18 who is not directly involved in the litigation will be able to. Often court officials are also able to serve process, which must be done in-person rather than via mail. Upon completion of this task, the defendant is able to legally participate in court proceedings. Because GlaxoSmithKline waived their formal service of process, newly-arriving complaints against Zofran will not be required to go through a process server before being delivered to GSK’s corporate office or attorneys. This choice will allow the legal process to move ahead more efficiently for those involved.
The attorneys at Monheit Law realize that as things progress, there is typically still time for other lawsuits to be filed and to join with those currently in the MDL. They are currently working to ensure that all women who took Zofran while pregnant and who subsequently gave birth to a child with congenital defects will have the ability to consider exploring their legal options. These women and their children may be entitled to legal action and significant compensation. Attorneys at Monheit Law are now offering free legal consultations for those affected.
To request additional information on Zofran birth defect lawsuits, or to ask questions, please contact Michael Monheit,Esq., lead attorney at Monheit Law, by calling (877) 620-8411.
###
Contact ZofranLegal.com:
Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046
